Rory B. Riggs, Director at Royalty Pharma plc (RPRX), sold 567,804 shares at $39.05 ($13.3M) on 2022-03-21, disclosed to the SEC on 2022-03-21.
Open-market sale of $13.3M RPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 229,626 | $0 | 0.0% |
| 2 | $39.38 | 26,238 | $1.0M | 7.7% |
| 3 | $39.38 | 26,238 | $1.0M | 7.7% |
| 4 | $39.38 | 46,803 | $1.8M | 13.8% |
| 5 | $39.38 | 46,803 | $1.8M | 13.8% |
| 6 | $39.77 | 56,181 |
| $2.2M |
| 16.8% |
| 7 | $39.77 | 56,181 | $2.2M | 16.8% |
| 8 | $39.05 | 14,322 | $559K | 4.2% |
| 9 | $39.05 | 14,322 | $559K | 4.2% |
| 10 | $39.05 | 25,545 | $998K | 7.5% |
| 11 | $39.05 | 25,545 | $998K | 7.5% |
| Total | $23.49 avg | 567,804 | $13.3M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |